Cipher Pharmaceuticals Inc.
CPHR
CPHR was delisted on the 8th of December, 2016.
3 hedge funds and large institutions have $10.1M invested in Cipher Pharmaceuticals Inc. in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 15 closing their positions.
63% less capital invested
Capital invested by funds: $27.3M → $10.1M (-$17.3M)
83% less funds holding
Funds holding: 18 → 3 (-15)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 15
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MBI
Montrusco Bolton Investments
Montreal,
Quebec, Canada
|
-$8.66M |
| 2 |
TAM
Taylor Asset Management
Toronto,
Ontario, Canada
|
-$3.81M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.02M |
| 4 |
IIM
Intact Investment Management
Montreal,
Quebec, Canada
|
-$1.78M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$206K |
CPHR Hedge Fund Activity: Q4 2016 in Review
3 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q4 2016, worth a combined $10.1M — down 63% from $27.3M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of CPHR and 0 opened new positions — a net loss of 15 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Montrusco Bolton Investments, exiting entirely with an estimated $8.66M sold.
- 3 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q4 2016, down from 18 in Q3 2016.
- Funds reported $10.1M of Cipher Pharmaceuticals Inc. stock for Q4 2016, down 63% quarter-over-quarter.
- 0 funds opened new Cipher Pharmaceuticals Inc. positions in Q4 2016 and 15 closed out, a net change of -15 holders.
- The largest Cipher Pharmaceuticals Inc. seller in Q4 2016 was Montrusco Bolton Investments, an estimated $8.66M sold.
Based on aggregated 13F filings for Q4 2016.